New daily pill aims to shed pounds in 12-Month obesity trial
Disease control
Ongoing
This study tests a new tablet called VCT220 to help overweight or obese adults lose weight. About 840 participants will take either a high dose, low dose, or placebo pill once daily for 12 months. The main goal is to see how much weight they lose and if it improves health markers…
Phase: PHASE3 • Sponsor: Vincentage Pharma Co., Ltd • Aim: Disease control
Last updated May 17, 2026 02:20 UTC